CXCL8 and rheumatoid arthritis: Treatment of fibroblast-like synoviocytes (FLS) isolated from rheumatoid arthritis (RA) patients with agonists of α7 nAChR reduced the levels of the pro-inflammatory cytokines IL-6 and IL-8 [13].